Penn Spinout Vittoria Biotherapeutics Emerges from Stealth Mode with $10M Seed Round

By BioBuzz Networks · Published December 2, 2024 · 1 min read

The new company hopes to overcome the current limitations of CAR T-cell therapeutics by using unique cell engineering and gene editing technologies.

Read the full article at: www.bizjournals.com

Tagged:

BioBuzz is a life science media and community organization connecting professionals, companies, and organizations across the Mid-Atlantic region.

Upcoming Events